Zh.Z. SHAGALEEVA^1,2, A.N. SAMOYLOV^1,2

¹Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012

²Republic Clinical Ophthalmology Hospital of the Ministry of Health Care of the Republic of Tatarstan, 14 Butlerov St., Kazan, Russian Federation, 420012

Shagaleeva Zh.Z. ― Assistant of the Ophthalmology Department, tel. +7-905-310-58-80, e-mail: Gannylkash@yandex.ru

Samoylov A.N. ― D. Med. Sc., Professor, Head of the Ophthalmology Department, tel. (843) 238-95-93, e-mail: Samoilov@nm.ru 

Currently, the leading cause of blindness among working-age population has become diabetic retinopathy (DR), i.e. the latest non-specific vascular event of diabetes mellitus. The basic principle of DR treatment is optimal compensation of diabetes mellitus and related problems: arterial hypertension, nephropathy, and hyperlipidemia. The main treatment that reduces the risk of development of type 1 diabetes mellitus vascular events is insulin therapy. The most optimal and promising method of insulin injections in patients with DR is the insulin pump, which is explained by a number of advantages.

A clinical event in the patient with type 1 diabetes mellitus, suffering from diabetic retinopathy is described in the article. The analysys of the change dynamics of the objective state of a visual organ, carbohydrate metabolism (variability of blood glucose), blood biochemical parameters (blood glucose, glycated hemoglobin), depending on the method of glycemia correction, was performed.

Key words: diabetes mellitus, diabetic retinopathy, hyperglycemia, insulin therapy, insulin pump.